1. Efficacy and safety of co‐crystal of tramadol‐celecoxib (CTC) in acute moderate‐to‐severe pain after abdominal hysterectomy: A randomized, double‐blind, phase 3 trial (STARDOM2). (24th September 2022) Authors: Langford, Richard; Morte, Adelaida; Sust, Mariano; Cebrecos, Jesús; Vaqué, Anna; Ortiz, Esther; Fettiplace, James; Adeyemi, Shola; Raba, Grzegorz; But‐Husaim, Liudmila; Gascón, Neus; Plata‐Salamán, Carlos Journal: European journal of pain Issue: Volume 26:Number 10(2022) Page Start: 2083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension. (13th July 2019) Authors: van Vollenhoven, Ronald F; Navarra, Sandra V; Levy, Roger A; Thomas, Mathew; Heath, Amy; Lustine, Todd; Adamkovic, Anthony; Fettiplace, James; Wang, Mei-Lun; Ji, Beulah; Roth, David Journal: Rheumatology Issue: Volume 59:Number 2(2020) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S107 More Than Just an Itch: Impact of Cholestatic Pruritus in Primary Biliary Cholangitis (PBC) on Health-Related Quality of Life (HRQoL). (October 2022) Authors: Smith, Helen; Fettiplace, James; Von Maltzahn, Robyn; Das, Sugato; Jones, David Other Names: McLaughlin Megan M. presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S19 Investigation of Linerixibat 40 Mg BID for Cholestatic Pruritus of Primary Biliary Cholangitis; Further Data From the Phase 2b GLIMMER Study to Support the Phase 3 GLISTEN Study. (October 2022) Authors: Fettiplace, James; Swift, Brandon; Zhang, Shu; Von Maltzahn, Robyn Other Names: McLaughlin Megan M. presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus. Issue 7 (5th June 2019) Authors: Wallace, Daniel J.; Ginzler, Ellen M.; Merrill, Joan T.; Furie, Richard A.; Stohl, William; Chatham, W. Winn; Weinstein, Arthur; McKay, James D.; McCune, W. Joseph; Petri, Michelle; Fettiplace, James; Roth, David A.; Ji, Beulah; Heath, Amy Journal: Arthritis & rheumatology Issue: Volume 71:Issue 7(2019) Page Start: 1125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗